Why women are not participating in clinical trials for cardiovascular disease and need to do so

The underrepresentation of women in clinical trials for cardiovascular disease treatments is a concerning issue that demands our attention. Why do fewer women participate? Are they less frequently invited to take part, or do they tend to drop out of the study more often during the research process?

Researchers of the Marie Curie study have taken up the challenge to address these questions. Their goal is to thoroughly investigate the reasons behind women's non-participation and explore the factors contributing to their higher dropout rates. Moreover, they are determined to uncover what motivates women to actively participate in these crucial studies.

Read more about the Marie Curie study via www.hartstichting.nl (in Dutch)